NCT04354246 2025-05-22COM902 (A TIGIT Inhibitor) in Subjects With Advanced MalignanciesCompugen LtdPhase 1 Active not recruiting110 enrolled
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT00036790 2019-12-17Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerUniversity of Wisconsin, MadisonPhase 1 Completed
NCT02457650 2016-08-03T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesShenzhen Second People's HospitalPhase 1 Unknown36 enrolled
NCT00024063 2013-12-19SU006668 in Treating Patients With Advanced Solid TumorsNational Cancer Institute (NCI)Phase 1 Unknown
NCT00475956 2010-04-15Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursAstraZenecaPhase 1 Completed40 enrolled